Bank Of New York Mellon Corp Arcellx, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$26.92 - $33.94 $3.37 Million - $4.24 Million	125,021 New	125,021 $3.85 Billion
Q4 2022 Feb 14, 2023	BUY	$17.18 - $33.0 $2.25 Million - $4.33 Million	131,165 New	131,165 $4.06 Million
Q3 2022 Nov 14, 2022	BUY	$16.67 - $22.04 $1.09 Million - $1.43 Million	65,101 Added 117.22%	120,637 $2.26 Million
Q2 2022 Aug 15, 2022	BUY	$7.21 - $24.43 $229,530 - $777,729	31,835 Added 134.32%	55,536 $1 Million
Q1 2022 May 11, 2022	BUY	$12.97 - $19.14 $307,401 - $453,637	23,701 New	23,701 $332,000

210

44.2M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.93B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.